Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-262172 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 8, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
4,140
Total Value
$0.00
P&L
+inf% (+$119,190.60)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 5, 2026 | Grant/Award | 570 | $0.00 | $0.00 | 22,870 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 5, 2026 | Grant/Award | 3,570 | $0.00 | $0.00 | 3,570 | Direct | โ | View Details |